全球化学品在线数据库
| CAS 登录号 | 产品名称 | 分子式 |
|---|---|---|
| 465514-85-6 | 1-(2-Fluoro-5-Nitrophenyl)-2,5-Dimethyl-1H-Pyrrole;0131011-(2-Fluoro-5-Nitrophenyl)-2,5-Dimethyl-1H-Pyrrole;1-(2-Fluoro-5-Nitrophenyl)-2,5-Dimethyl-1H-Pyrrole, 95%+;3-(2,5-Dimethyl-1H-Pyrrol-1-Yl)-4-Fluoronitrobenzene | C12H11FN2O2 |
| 465515-31-5 | 5-Carboxythiophene-2-boronic acid;2-Carboxythiophene-5-boronic acid; 5-Boronothiophene-2-carboxylic acid; 5-(Dihydroxyboryl)-2-thiophenecarboxylic acid | C5H5BO4S |
| 465515-36-0 | 1-Benzothiophene-3-Carboximidamide Hydrochloride Hydrate;1-Benzoth<wbr>iophene-3<wbr>-carboxim<wbr>idamide h<wbr>ydrochlor<wbr>ide hydra<wbr>te, 3-Car<wbr>bamimidoy<wbr>lbenzo[b]<wbr>thiophene<wbr> hydrochl<wbr>oride hyd<wbr>rate;Benzo[b]thiophene-3-carboxamidine hydrochloride hydrate;Benzo[b]thiophene-3-carboximidamidine hydrochloride hydrate | C9H11ClN2OS |
| 465521-19-1 | (3-Furylethynyl)(Trimethyl)Silane;(3-Furylethynyl)trimethylsilane;4-(3-furyl)-2,2-dimethyl-2-silabut-3-yne;FURAN,3-[2-(TRIMETHYLSILYL)ETHYNYL]- | C9H12OSi |
| 465527-59-7 | Trihexyl(Tetradecyl)Phosphonium Bis(2,4,4-Trimethylpentyl)Phosphinate;CYPHOSIL104;Tetradecy<wbr>ltrihexyl<wbr>phosphoni<wbr>um bis(2,<wbr>4,4-trime<wbr>thylpenty<wbr>l)phosphi<wbr>nate;Trihexylt<wbr>etradecyl<wbr>phosphoni<wbr>um bis(2,<wbr>4,4-trime<wbr>thylpenty<wbr>l)phosphi<wbr>nate | C48H102O2P2 |
| 465527-65-5 | Trihexyl(Tetradecyl)Phosphonium Decanoate;tetradecyl(trihexyl)phosphonium decanoate;Tetradecyltrihexylphosphonium decanoate;trihexyltetradecylphosphonium decanoate | C42H87O2P |
| 465529-56-0 | 5-Bromo-2-methyl-2H-indazole | C8H7BrN2 |
| 465529-57-1 | 5-Bromo-1-methyl-1H-indazole | C8H7BrN2 |
| 465530-93-2 | N,N,3,5-Tetramethyl-1-Piperazinecarboxamide;1-Piperazinecarboxamide, N,N,3,5-tetramethyl-;N,N,3,5-Tetramethyl-1-piperazincarboxamid;N,N,3,5-Tetramethyl-1-piperazinecarboxamide | C9H19N3O |
| 465536-44-1 | (4S,4aS,8aS)-4-Phenyldecahydro-4-Quinolinol;(4S,4aS,8aS)-4-phenyldecahydro-4-quinolinol;4-PHENYL-DECAHYDRO-QUINOLIN-4-OL;MFCD00810931 | C15H21NO |
| 466639-53-2 | 3-Bromo-4-iodoanisole;2-Bromo-1-iodo-4-methoxybenzene | C7H6BrIO |
| 466678-44-4 | Lactosyl Pregabalin Pyrrolidone;(4S)-1-[(2R,3R,4R,5S,6R)-3,4-dihydroxy-6-(hydroxymethyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]-4-(2-methylpropyl)pyrrolidin-2-one | C20H35NO11 |
| 467214-20-6 | Alvespimycin;17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin; 17-DMAG | C32H48N4O8 |
| 467214-21-7 | Alvespimycin hydrochloride;17-DMAG hydrochloride; BMS 826476; KOS 1022; 17-Demethoxy-17-[[2-(dimethylamino)ethyl]amino]geldanamycin hydrochloride | C32H48N4O8.HCl |
| 467214-46-6 | 6-Chloro-1H-indol-3-yl alpha-D-glucopyranoside | C14H16ClNO6 |
| 467220-49-1 | 1,3-Bis(2,4,6-trimethylphenyl)imidazol-2-ylidene (1,4-naphthoquinone)palladium dimer | C62H60N4O4Pd2 |
| 467223-90-1 | 3,5-Difluorobenzeneethanol | C8H8F2O |
| 467435-07-0 | 4-Bromo-2-chlorobenzotrifluoride | C7H3BrClF3 |
| 467435-58-1 | 32,35-Bis[2-[(2,4-diethylheptyl)oxy]ethoxy]-6,7,9,10,12,13,15,16,18,19-decahydro-31H-4,21-(methano[1,3]benzenomethano)-26,30-metheno-25H-dibenzo[q,z][1,4,7,10,13,16]hexaoxacycloheptacosin | C64H94O10 |
| 467442-12-2 | 3,5-Difluoro-4-formylbenzoic acid 1,1-dimethylethyl ester | C12H12F2O3 |
| 467442-15-5 | 4-Cyano-2,6-difluorobenzaldehyde;3,5-Difluoro-4-formylbenzonitrile | C8H3F2NO |
| 467442-20-2 | (S)-2-(tert-Butoxycarbonylamino)-4,4-difluorobutanoic acid | C9H15F2NO4 |
| 467451-91-8 | 6-Trifluoromethoxy-1H-indole | C9H6F3NO |
| 467458-02-2 | N-[2-(6-Fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine monohydrochloride | C20H19F5N2O.HCl |
| 467458-46-4 | 3-Formyl-1H-indole-5-carboxylic acid ethyl ester;3-Formyl-5-ethoxycarbonyl-1H-indole | C12H11NO3 |
| 467459-31-0 | N-[2-(6-Fluoro-1H-indol-3-yl)ethyl]-3-(2,2,3,3-tetrafluoropropoxy)benzylamine;Lu AE 58054 | C20H19F5N2O |
| 467461-40-1 | 6-(Methylsulfonyl)-1H-Indole;1H-Indol-6-yl methyl sulfone;1H-Indol-6-yl methyl sulphone;6-(methylsulfonyl)indole | C9H9NO2S |
| 468068-28-2 | 6-Amino-N-Hydroxy-3-Pyridinecarboximidamide;5-(2-AMINOPYRIDYL)AMIDE OXIME;5-(2-Aminopyridyl)amidoxime;6-Amino-N-hydroxy-nicotinamidine | C6H8N4O |
| 468068-39-5 | 6-Chloro-N'-Hydroxy-3-Pyridinecarboximidamide;(6-chloro(3-pyridyl))(hydroxyimino)methylamine;(Z)-6-chloro-N'-hydroxypyridine-3-carboximidamide;4-deoxypy<wbr>ridoxine <wbr>hydrochlo<wbr>ride,2,4-<wbr>dimethyl-<wbr>3-hydroxy<wbr>-5-hydrox<wbr>y methylp<wbr>yridine h<wbr>ydrochlor<wbr>ide | C6H6ClN3O |
| 468068-58-8 | 2-Chloro-N'-Hydroxy-3-Pyridinecarboximidamide;(2-chloro(3-pyridyl))(hydroxyimino)methylamine;2-Chloro-N'-hydroxy-3-pyridinecarboximidamide;2-Chloro-N-hydroxy-nicotinamidine | C6H6ClN3O |
| 468074-91-1 | 1-[2-Methoxy-5-(Trifluoromethoxy)Phenyl]Ethanol;1-[2-Methoxy-5-(trifluoromethoxy)phenyl]ethan-1-ol;1-[2-Methoxy-5-(trifluoromethoxy)phenyl]ethan-1-ol?;MFCD08062374 | C10H11F3O3 |
| 468074-92-2 | 1-[2-Methoxy-5-(Trifluoromethoxy)Phenyl]Ethanone;1-acetyl-2-methoxy-5-(trifluoromethoxy)benzene;2'-Methoxy-5'-(trifluoromethoxy)acetophenone?;MFCD08062375 | C10H9F3O3 |
| 468075-00-5 | 2-Bromo-1-chloro-4-(trifluoromethoxy)benzene | C7H3BrClF3O |
| 468095-63-8 | 2,3,4,6-Tetra-O-Benzyl-1-O-[(Z)-{[4-(Trifluoromethyl)Benzyl]Sulfanyl}{[4-(Trifluoromethyl)Phenyl]Imino}Methyl]-alpha-D-Glucopyranose;2,3,4,6-T<wbr>etra-O-be<wbr>nzyl-α-D-<wbr>glucopyra<wbr>nosyl p-T<wbr>rifluorom<wbr>ethylbenz<wbr>ylthio-N-<wbr>(p-triflu<wbr>oromethyl<wbr>phenyl)fo<wbr>rmimidate | C50H45F6NO6S |
| 468718-16-3 | 5-(Trifluoromethyl)-1H-indole-3-carboxaldehyde | C10H6F3NO |
| 468718-30-1 | 5-Cyano-2-fluorophenylboronic acid;5-Cyano-2-fluorobenzeneboronic acid | C7H5BFNO2 |
| 468718-67-4 | 3-Chloro-N-Methyl-2-Pyridinamine;(3-chloro(2-pyridyl))methylamine;(3-Chloro-pyridin-2-yl)-methyl-amine;2-Pyridinamine,3-chloro-N-methyl- | C6H7ClN2 |
| 468740-43-4 | BMS-536924;Insulin-like Growth Factor-1 Receptor Inhibitor; 4-[[(2S)-2-(3-Chlorophenyl)-2-hydroxyethyl]amino]-3-[7-methyl-5-(4-morpholinyl)-1H-benzimidazol-2-yl]-2(1H)-pyridinone | C25H26ClN5O3 |
| 468741-20-0 | 2-Methyl-4-(4-Morpholinyl)-6-Nitro-Benzenamine;2-METHYL-4-MORPHOLINO-6-NITROANILINE | C11H15N3O3 |
| 468747-17-3 | mTOR inhibitor-1;3-bromo-N-[1-(2,4-dihydroxyphenyl)ethylideneamino]-4-methylbenzamide | C16H15BrN2O3 |
| 468751-38-4 | 2-(Phenylsulfonylmethyl)benzaldehyde | C14H12O3S |
| 468756-78-7 | 7-Chloro-2-ethyl-1H-indene | C11H11Cl |
| 469912-82-1 | 2,5-Bis(trimethylstannyl)thieno[3,2-b]thiophene | C12H20S2Sn2 |
| 470442-95-6 | 4-(1-Piperazinyl)-2-Pyridinamine;2-Amino-4-(piperazin-1-yl)pyridine;2-Pyridinamine,4-(1-piperazinyl)-;4-(piperazin-1-yl)pyridin-2-amine | C9H14N4 |
| 470458-51-6 | 3,5-Difluoro-N-Methylaniline;3,4-difluoro-N-methylaniline;N-Methyl 3,5-difluoroaniline | C7H7F2N |
| 470463-34-4 | 2-(2,2-Dimethyl-Propionylamino)-Isonicotinic Acid;2-(2,2-Dimethyl-Propionylamino)-Isonicotinic Acid | C11H14N2O3 |
| 470463-35-5 | 2-Chloro-3-[(Trimethylsilyl)Ethynyl]Pyridine;2-chloro-3-((trimethylsilyl)ethynyl)pyridine;2-Chloro-3-trimethylsilanylethynyl-pyridine;MFCD04039859 | C10H12ClNSi |
| 470463-36-6 | N-(5-Iodo-Pyridin-2-Yl)-2,2-Dimethyl-Propionamide;N-(5-Iodo-2-Pyridyl)-2,2-Dimethyl-Propanamide;N-(5-Iodo-2-Pyridyl)-2,2-Dimethylpropanamide;N-(5-Iodo-2-Pyridyl)-2,2-Dimethyl-Propionamide | C10H13IN2O |
| 470463-37-7 | 2-[(2,2-Dimethyl-1-Oxopropyl)Amino]-4-Pyridinecarboxamide;2-(2,2-Dimethyl-Propionylamino)-Isonicotinamide | C11H15N3O2 |
| 470463-39-9 | 2-[(2,2-Dimethyl-1-Oxopropyl)Amino]-4-Pyridinecarboxylicacid Hydrazide;Ambad104 | C11H16N4O2 |